- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05268094
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) (COMPASS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Allison Crosby-Thompson
- Phone Number: 339-215-6593
- Email: allison.crosby-thompson@carelon.com
Study Contact Backup
- Name: Rachna Kumar
- Email: rachna.kumar@carelon.com
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- Not yet recruiting
- Hospital for Sick Children
-
Contact:
- Martha Rolland
- Email: martha.rolland@sickkids.ca
-
Principal Investigator:
- Rajiv Chaturvedi, MD, PhD
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Recruiting
- University of Alabama
-
Contact:
- Krissie Hock
- Email: khock@peds.uab.edu
-
Principal Investigator:
- Mark Law, MD
-
-
Arizona
-
Phoenix, Arizona, United States, 85016
- Recruiting
- Phoenix Children's Hospital
-
Contact:
- Jade Porche
- Email: jporche@phoenixchildrens.com
-
Principal Investigator:
- Joseph Graziano, MD
-
-
California
-
Los Angeles, California, United States, 90027
- Not yet recruiting
- Children's Hospital Los Angeles
-
Contact:
- Carly Weaver
- Email: cweaver@chla.usc.edu
-
Oakland, California, United States, 94609
- Recruiting
- UCSF Benioff Children's Hospitals
-
Contact:
- Disha Goel
- Email: disha.goel@ucsf.edu
-
Principal Investigator:
- Jeffery Meadows, MD
-
Palo Alto, California, United States, 94304
- Recruiting
- Stanford Children's Health
-
Contact:
- Sandra Moon
- Email: smoon3@stanford.edu
-
Principal Investigator:
- Lynn Peng, MD
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Recruiting
- Children's Hospital of Colorado
-
Contact:
- Megyn Gordan
- Email: megyn.gordon@childrenscolorado.org
-
Principal Investigator:
- Michael DiMaria, MD
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Recruiting
- Children's National Medical Center
-
Contact:
- Alix Fetch
- Email: afetch@childrensnational.org
-
Principal Investigator:
- Tacy Downing, MD
-
-
Florida
-
Hollywood, Florida, United States, 33021
- Recruiting
- Joe DiMaggio Children's Hospital
-
Contact:
- Doris Alaby
- Email: dalaby@mhs.net
-
Contact:
- Kathleen Hathaway
- Email: KHathaway@mhs.net
-
Principal Investigator:
- Peter Guyon, MD
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Recruiting
- Children's Healthcare of Atlanta
-
Contact:
- Laura Price
- Email: Laura.Price@choa.org
-
Principal Investigator:
- Dennis Kim, MD, PhD
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Boston Children's Hospital
-
Contact:
- Thomas Giorgio
- Email: Thomas.Giorgio@cardio.chboston.org
-
Contact:
- Simran
-
Principal Investigator:
- Nicola Maschietto, MD, PhD
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- Recruiting
- University of Michigan
-
Principal Investigator:
- Jeffrey Zampi, MD
-
Contact:
- Tammy Doman
- Email: tpaterso@med.umich.edu
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Recruiting
- Washington University School of Medicine
-
Contact:
- Abigail Waldron
- Email: wabigail@wustl.edu
-
Contact:
- Mason Basler
- Email: basler@wustl.edu
-
Principal Investigator:
- Andrew Glatz, MD. MSCE
-
-
New York
-
New York, New York, United States, 10032
- Recruiting
- New York Presbyterian Hospital/Columbia University Irving Medical Center
-
Contact:
- Rachel Weber
- Email: rw2727@cumc.columbia.edu
-
Principal Investigator:
- Christopher Petit, MD
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28203
- Recruiting
- Levine Children's Hospital
-
Principal Investigator:
- Matthew Schwartz, MD
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Recruiting
- Cincinnati Children's Hospital Medical Center
-
Contact:
- Lauryn Dugan, MD
- Email: lauryn.dugan@cchmc.org
-
Principal Investigator:
- David Winlaw, MD
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- Children's Hospital of Philadelphia
-
Contact:
- Alekhya Nanduri
- Email: nanduria@chop.edu
-
Principal Investigator:
- Michael O'Byrne, MD, MSCE
-
Pittsburgh, Pennsylvania, United States, 15213
- Recruiting
- University of Pittsburgh Medical Center
-
Contact:
- Niklas Gerhart
- Email: gerhartne4@upmc.edu
-
Principal Investigator:
- Bryan Goldstein, MD
-
Contact:
- Shannon Janzef
- Email: janzefsl@upmc.edu
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Recruiting
- Medical University of South Carolina
-
Contact:
- Layla Al Sarraf
- Email: alsarral@musc.edu
-
Principal Investigator:
- John Costello, MD, MPH
-
-
Tennessee
-
Memphis, Tennessee, United States, 38105
- Not yet recruiting
- Le Bonheur Children's Hospital
-
Contact:
- Kathryn Carpenter
- Email: Kathryn.carpenter@lebonheur.org
-
Principal Investigator:
- Shyam K Sathanandam, MD
-
-
Texas
-
Dallas, Texas, United States, 75235
- Not yet recruiting
- UT Southwestern Medical Center
-
Contact:
- Kara Lorduy
- Email: Kara.Lorduy@childrens.com
-
Contact:
- Glenda Moate
- Email: glenda.moate@childrens.com
-
Principal Investigator:
- Surendranath Veeram Reddy, MD
-
Houston, Texas, United States, 77030
- Recruiting
- Texas Children's Hospital
-
Contact:
- Thao (Debbie) Wu
- Email: ttwu@texaschildrens.org
-
Principal Investigator:
- Athar Qureshi, MD
-
-
Utah
-
Salt Lake City, Utah, United States, 84113
- Recruiting
- Primary Children's Hospital
-
Contact:
- Andrea Curless
- Email: andrea.curless@hsc.utah.edu
-
Principal Investigator:
- Dana Boucek, MD, MSCI
-
-
Wisconsin
-
Wauwatosa, Wisconsin, United States, 53226
- Recruiting
- Children's Wisconsin
-
Contact:
- Jennifer Yauck
- Email: jyauck@chw.org
-
Principal Investigator:
- Susan Foerster, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Neonates with Congenital Heart Disease (CHD) and ductal-dependent pulmonary blood flow requiring only a stable source of pulmonary blood flow as the initial palliation, for whom the clinical decision is made at the enrolling center that this is best achieved by either DAS or SPS.
- Age ≤ 30 days at time of index procedure (DAS or SPS).
Exclusion Criteria:
1. Any patient for whom the clinical decision at the enrolling center is that an initial intervention other than DAS or SPS is indicated (e.g., Right Ventricle-Pulmonary Artery (RV-PA) conduit, Right Ventricular Outflow Tract (RVOT) stent, primary complete anatomic repair, etc.).
2. Pulmonary Atresia with Intact Ventricular Septum (PA/IVS) where Right Ventricle (RV) decompression is planned.
3. Presence of MAPCAs: defined as an aortopulmonary collateral that is expected to require unifocalization.
4. Non-confluent Pulmonary Arteries (i.e., isolated Pulmonary Artery (PA) of ductal origin).
5. Acutely jeopardized branch Pulmonary Arteries (>75% narrowing of proximal PA based on screening cross sectional imaging [Computed Tomography Angiography (CTA) or cardiovascular Magnetic Resonance (cMR)]).
6. Bilateral Patent Ductus Arteriosis (PDA). 7. Patient who, at the time of enrollment, is deemed not to be a candidate for eventual Glenn or Complete Surgical Repair (CSR) for any reason.
8. Birth weight <2.0 kg. 9. Gestational age <34 weeks at birth. 10. Patient for whom additional intervention is expected concomitant with, or prior to, DAS or SPS (e.g., atrial septostomy, aortic arch intervention, or RV outflow tract intervention) - except for branch PA arterioplasty or stent/balloon angioplasty.
11. Major co-morbidities which, in the opinion of the investigator, would negatively alter expected 1-year survival (e.g., intracranial hemorrhage, renal failure, etc.).
12. Specific known genetic anomaly which, in the opinion of the investigator, would be expected to significantly alter clinical course in the first year of life (e.g., Trisomy 13/18, CHARGE, VACTERL).
13. Patient who does not plan to return to the enrolling center or another participating center for Glenn/CSR.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ductal Artery Stent
Transcatheter ductal artery shunt will be placed by the interventional team.
Drug-eluting coronary stent brand, length, and diameter are determined by the interventional team.
|
Drug-eluting ductal arterial stents will be placed by transcatheter method.
Other Names:
|
Experimental: Systemic-to-Pulmonary Artery Shunt
Surgical systemic-to-pulmonary artery shunt performed by the interventional team.
SPS diameter, length, and material will be determined by the surgeon performing the intervention.
|
A surgical connection will be made between a systemic artery and the pulmonary artery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Morbidity and/or Mortality Endpoint
Time Frame: 1 year
|
Rates of a composite major morbidity and/or mortality endpoint in the first year of life will be compared between neonates with ductal-dependent pulmonary blood flow randomized to receive either DAS or SPS as the initial palliation.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global Rank Score
Time Frame: 1 year
|
All participants will be assigned a Global Rank Score, which is a rank based on a pre-specified hierarchical ranking of outcomes.
This combines various endpoints into a single quantifiable endpoint with weighting of the severity of the component endpoints, and allows for the inclusion of endpoints of different forms.
Global rank scores will range from 1-7.
|
1 year
|
Freedom from Adverse Events
Time Frame: 1 year
|
Safety, defined as freedom from procedural adverse events and complications, will be tracked and evaluated.
|
1 year
|
Days Alive out of Hospital
Time Frame: 1 year
|
Days alive out of the hospital represents a patient-centered outcome, and functions as a composite endpoint.
|
1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Christopher Petit, MD, Columbia University
- Study Chair: Andrew Glatz, MD, Washington University School of Medicine
- Study Chair: Sara Pasquali, MD, University of Michigan
- Study Chair: Jenna Romano, MD, University of Michigan
- Study Chair: Jeffrey Zampi, MD, University of Michigan
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHNCOMPASS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Disease in Children
-
Children's Mercy Hospital Kansas CityChildren's Hospital of Philadelphia; University of North Carolina, Chapel Hill and other collaboratorsRecruitingCongenital Heart Disease in ChildrenUnited States
-
University Hospital, Strasbourg, FranceRecruitingCongenital Heart Disease in ChildrenFrance
-
University Children's Hospital, ZurichCompletedCongenital Heart Disease in ChildrenSwitzerland
-
Stanford UniversityNational Institutes of Health (NIH)Not yet recruitingCongenital Heart Disease in Children
-
Johns Hopkins UniversityRecruitingCongenital Heart Disease in ChildrenUnited States
-
Assiut UniversityNot yet recruitingCommon Cases in Pediatric Intensive Care in Assuit University Cardiology Institute, a Clinical AuditCongenital Heart Disease in Children
-
Xinhua Hospital, Shanghai Jiao Tong University...RecruitingCongenital Heart Disease in ChildrenChina
-
Queen Fabiola Children's University HospitalTerminatedCongenital Heart Disease in ChildrenBelgium
-
Boston Children's HospitalThe Hospital for Sick Children; Baylor College of Medicine; Children's Hospital... and other collaboratorsRecruitingCongenital Heart Disease in ChildrenUnited States, Canada
-
University Hospital, Strasbourg, FranceCompletedCongenital Heart Disease in ChildrenFrance
Clinical Trials on Ductal Arterial Stent
-
University of Michigan Rogel Cancer CenterTerminatedBreast CancerUnited States
-
University of MichiganWayne State UniversityCompleted
-
John Paul II Hospital, KrakowUnknownPeripheral Vascular DiseasesPoland
-
M.D. Anderson Cancer CenterCompletedBreast CancerUnited States
-
Fudan UniversityShanghai Weihe Medical Laboratory Co., Ltd.Not yet recruitingPancreatic Ductal AdenocarcinomaChina
-
Tianjin Huanhu HospitalRecruiting
-
University of PatrasUnknownArterial Access in Percutaneous Coronary Angiography or InterventionGreece
-
Weill Medical College of Cornell UniversitySunnybrook Health Sciences Centre; Columbia University; Duke University; Cedars-Sinai... and other collaboratorsRecruitingHeart Diseases | Coronary Artery Disease | Coronary Artery Bypass GraftingUnited States, Austria, Israel, Canada, Korea, Republic of, Spain, Sweden, Croatia, Germany, United Kingdom, China, Poland, Italy, Brazil, Czechia, India, Japan, Netherlands, Portugal, Serbia, Singapore, Taiwan, Australia, North Macedonia and more
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health...Active, not recruitingHeart Diseases | Coronary Artery DiseaseUnited States, Brazil, Canada, Singapore, Italy, Germany, China, Croatia, Serbia, Portugal, Austria, Czechia, Japan, Korea, Republic of, Netherlands, Poland, Spain